The Enterprise Value as of November 2024 (TTM) for Surrozen, Inc. (SRZN) is -334650.00

According to Surrozen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -334650.00. This represents a change of -96.01% compared to the average of -8393893.11 of the last 4 quarters.

Surrozen, Inc. (SRZN) Historical Enterprise Value (quarterly & annually)

How has SRZN Enterprise Value performed in the past?

The mean historical Enterprise Value of Surrozen, Inc. over the last ten years is 64.55M. The current -334650.00 Enterprise Value has changed -151.84% with respect to the historical average. Over the past ten years (40 quarters), SRZN's Enterprise Value was at its highest in in the December 2020 quarter at 5.29B. The Enterprise Value was at its lowest in in the June 2023 quarter at -15427855.50.

Surrozen, Inc. (SRZN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Surrozen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Surrozen, Inc. (SRZN) Average Enterprise Value

How has SRZN Enterprise Value performed in the past?

The current Enterprise Value of Surrozen, Inc. (SRZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Surrozen, Inc. (SRZN) Enterprise Value vs. Peers

How is SRZN’s Enterprise Value compared to its peers?

Surrozen, Inc.’s Enterprise Value is less than Bolt Biotherapeutics, Inc. (38.25M), less than Larimar Therapeutics, Inc. (451.08M), less than Keros Therapeutics, Inc. (1.86B), less than Kezar Life Sciences, Inc. (41.43M), less than Processa Pharmaceuticals, Inc. (831.36K), greater than NexImmune, Inc. (-2120074.00), less than Evelo Biosciences, Inc. (16.69M), less than Tempest Therapeutics, Inc. (14.24M), less than Replimune Group, Inc. (748.25M), less than Nuvectis Pharma, Inc. (99.68M), less than Lyra Therapeutics, Inc. (21.94M), less than Kronos Bio, Inc. (14.20M), less than Gossamer Bio, Inc. (310.67M), less than ERYTECH Pharma S.A. (43.57M), less than Aptorum Group Limited (8.77M), less than Unicycive Therapeutics, Inc. (50.19M), less than Armata Pharmaceuticals, Inc. (205.85M), less than CytomX Therapeutics, Inc. (46.14M), less than Instil Bio, Inc. (257.40M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Spero Therapeutics, Inc. (11.67M), less than Assembly Biosciences, Inc. (85.72M),

Build a custom stock screener for Surrozen, Inc. (SRZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surrozen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surrozen, Inc. (SRZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surrozen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.